WIPO COORDINATES GLOBAL PHARMA KNOWLEDGE DATABASE
November 1st, 2011
BY KEITH NUTHALL
A PUBLIC searchable database of pharmaceutical-related intellectual property assets will be run by a global consortium involving major pharma companies including Alnylam Pharmaceuticals, AstraZeneca, Eisai, GlaxoSmithKline, MSD, Novartis, Pfizer, and Sanofi. They are working with the World Intellectual Property Organisation (WIPO), BIO Ventures for Global Health (BVGH) and major research organisations. Together they have launched WIPO Re:Search. With a wide range of medicine information resources, the system, said a WIPO note, would ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.